CA1083036A - Methode indirecte pour le dosage des antigenes ou des anticorps sur une surface solide - Google Patents

Methode indirecte pour le dosage des antigenes ou des anticorps sur une surface solide

Info

Publication number: CA1083036A
Authority: CA; Canada
Prior art keywords: antigen; antibody; labelled; sample; support surface
Prior art date: 1977-10-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired

Application number

CA289,222A

Other languages

English (en)

Inventor

Gunner Bolz

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

International Diagnostic Technologies Inc

Original Assignee

International Diagnostic Technologies Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1977-10-21

Filing date

1977-10-21

Publication date

1980-08-05

1977-10-21 Application filed by International Diagnostic Technologies Inc filed Critical International Diagnostic Technologies Inc

1977-10-21 Priority to CA289,222A priority Critical patent/CA1083036A/fr

1980-08-05 Application granted granted Critical

1980-08-05 Publication of CA1083036A publication Critical patent/CA1083036A/fr

Status Expired legal-status Critical Current

Links

239000000427 antigen Substances 0.000 title claims abstract description 97
102000036639 antigens Human genes 0.000 title claims abstract description 97
108091007433 antigens Proteins 0.000 title claims abstract description 97
239000007787 solid Substances 0.000 title claims abstract description 24
238000012360 testing method Methods 0.000 title description 7
238000000034 method Methods 0.000 claims abstract description 60
239000007788 liquid Substances 0.000 claims abstract description 12
239000000243 solution Substances 0.000 claims description 32
238000001179 sorption measurement Methods 0.000 claims description 22
238000006243 chemical reaction Methods 0.000 claims description 16
230000001900 immune effect Effects 0.000 claims description 13
239000000126 substance Substances 0.000 claims description 13
239000003153 chemical reaction reagent Substances 0.000 claims description 12
102000004169 proteins and genes Human genes 0.000 claims description 9
108090000623 proteins and genes Proteins 0.000 claims description 9
239000000872 buffer Substances 0.000 claims description 6
102000004190 Enzymes Human genes 0.000 claims description 5
108090000790 Enzymes Proteins 0.000 claims description 5
239000000941 radioactive substance Substances 0.000 claims description 5
238000005406 washing Methods 0.000 claims description 5
238000001035 drying Methods 0.000 claims description 4
238000011534 incubation Methods 0.000 claims description 4
238000005259 measurement Methods 0.000 claims description 3
239000007795 chemical reaction product Substances 0.000 claims description 2
239000002184 metal Substances 0.000 claims 4
102000006830 Luminescent Proteins Human genes 0.000 claims 2
108010047357 Luminescent Proteins Proteins 0.000 claims 2
206010013786 Dry skin Diseases 0.000 claims 1
239000000047 product Substances 0.000 claims 1
238000003556 assay Methods 0.000 abstract description 9
238000001514 detection method Methods 0.000 abstract description 4
210000002966 serum Anatomy 0.000 description 22
230000008105 immune reaction Effects 0.000 description 13
238000003127 radioimmunoassay Methods 0.000 description 6
108060003951 Immunoglobulin Proteins 0.000 description 5
102000018358 immunoglobulin Human genes 0.000 description 5
239000000463 material Substances 0.000 description 5
239000002245 particle Substances 0.000 description 4
230000000274 adsorptive effect Effects 0.000 description 3
238000011088 calibration curve Methods 0.000 description 3
230000002860 competitive effect Effects 0.000 description 3
238000010790 dilution Methods 0.000 description 3
239000012895 dilution Substances 0.000 description 3
239000003456 ion exchange resin Substances 0.000 description 3
229920003303 ion-exchange polymer Polymers 0.000 description 3
-1 polyethylene Polymers 0.000 description 3
229920000642 polymer Polymers 0.000 description 3
230000002285 radioactive effect Effects 0.000 description 3
239000007790 solid phase Substances 0.000 description 3
102000003992 Peroxidases Human genes 0.000 description 2
239000004793 Polystyrene Substances 0.000 description 2
PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
230000003172 anti-dna Effects 0.000 description 2
238000010420 art technique Methods 0.000 description 2
239000007853 buffer solution Substances 0.000 description 2
238000000295 emission spectrum Methods 0.000 description 2
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
239000011521 glass Substances 0.000 description 2
229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
239000004926 polymethyl methacrylate Substances 0.000 description 2
229920002223 polystyrene Polymers 0.000 description 2
238000002360 preparation method Methods 0.000 description 2
239000000758 substrate Substances 0.000 description 2
NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
IOOMXAQUNPWDLL-UHFFFAOYSA-N 2-[6-(diethylamino)-3-(diethyliminiumyl)-3h-xanthen-9-yl]-5-sulfobenzene-1-sulfonate Chemical compound C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S(O)(=O)=O)C=C1S([O-])(=O)=O IOOMXAQUNPWDLL-UHFFFAOYSA-N 0.000 description 1
241000283707 Capra Species 0.000 description 1
239000004215 Carbon black (E152) Substances 0.000 description 1
239000004952 Polyamide Substances 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
229930003270 Vitamin B Natural products 0.000 description 1
150000001252 acrylic acid derivatives Chemical class 0.000 description 1
238000001261 affinity purification Methods 0.000 description 1
239000007975 buffered saline Substances 0.000 description 1
229920005549 butyl rubber Polymers 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
230000009137 competitive binding Effects 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
238000004925 denaturation Methods 0.000 description 1
230000036425 denaturation Effects 0.000 description 1
239000000032 diagnostic agent Substances 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
229920001971 elastomer Polymers 0.000 description 1
ZFKJVJIDPQDDFY-UHFFFAOYSA-N fluorescamine Chemical compound C12=CC=CC=C2C(=O)OC1(C1=O)OC=C1C1=CC=CC=C1 ZFKJVJIDPQDDFY-UHFFFAOYSA-N 0.000 description 1
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
238000001215 fluorescent labelling Methods 0.000 description 1
108010074605 gamma-Globulins Proteins 0.000 description 1
229920000578 graft copolymer Polymers 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
238000007654 immersion Methods 0.000 description 1
206010025135 lupus erythematosus Diseases 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
238000000386 microscopy Methods 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
229920000620 organic polymer Polymers 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
239000002953 phosphate buffered saline Substances 0.000 description 1
229920002647 polyamide Polymers 0.000 description 1
229920000728 polyester Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920001296 polysiloxane Polymers 0.000 description 1
229920002620 polyvinyl fluoride Polymers 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000002335 preservative effect Effects 0.000 description 1
239000012857 radioactive material Substances 0.000 description 1
239000000376 reactant Substances 0.000 description 1
239000005060 rubber Substances 0.000 description 1
229920000260 silastic Polymers 0.000 description 1
239000000741 silica gel Substances 0.000 description 1
229910002027 silica gel Inorganic materials 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
229920003051 synthetic elastomer Polymers 0.000 description 1
239000005061 synthetic rubber Substances 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
229910052715 tantalum Inorganic materials 0.000 description 1
GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
229920002554 vinyl polymer Polymers 0.000 description 1
235000019156 vitamin B Nutrition 0.000 description 1
239000011720 vitamin B Substances 0.000 description 1
235000012431 wafers Nutrition 0.000 description 1

Landscapes

Investigating Or Analysing Biological Materials (AREA)

CA289,222A 1977-10-21 1977-10-21 Methode indirecte pour le dosage des antigenes ou des anticorps sur une surface solide Expired CA1083036A (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA289,222A CA1083036A (fr)	1977-10-21	1977-10-21	Methode indirecte pour le dosage des antigenes ou des anticorps sur une surface solide

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA289,222A CA1083036A (fr)	1977-10-21	1977-10-21	Methode indirecte pour le dosage des antigenes ou des anticorps sur une surface solide

Publications (1)

Publication Number	Publication Date
CA1083036A true CA1083036A (fr)	1980-08-05

Family

ID=4109818

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA289,222A Expired CA1083036A (fr)	1977-10-21	1977-10-21	Methode indirecte pour le dosage des antigenes ou des anticorps sur une surface solide

Country Status (1)

Country	Link
CA (1)	CA1083036A (fr)

1977
- 1977-10-21 CA CA289,222A patent/CA1083036A/fr not_active Expired

Legal Events

Date	Code	Title	Description
1997-08-05	MKEX	Expiry

Publication	Publication Date	Title
US4067959A (en)	1978-01-10	Indirect solid surface test for antigens or antibodies
US4020151A (en)	1977-04-26	Method for quantitation of antigens or antibodies on a solid surface
EP0427984B2 (fr)	2000-12-27	Articles pour utilisation dans les techniques enzyme-immunoessais et méthodes pour fabriquer ces articles
CA1184114A (fr)	1985-03-19	Methode et dispositif d'analyse
US4219335A (en)	1980-08-26	Immunochemical testing using tagged reagents
CA1225586A (fr)	1987-08-18	Methode d'execution d'un dosage immunologique, articles utilises a cette fin et methode de production desdits articles
USRE29955E (en)	1979-04-03	Method of detecting antigens or antibodies
EP0154734B1 (fr)	1990-08-29	Essai pour la détection immédiate d'un ligand, trousse d'essai et sa préparation
US4568649A (en)	1986-02-04	Immediate ligand detection assay
US4242096A (en)	1980-12-30	Immunoassay for antigens
EP0745223A1 (fr)	1996-12-04	Procede de marquage de microparticules a l'acridinium et application a un instrument
JPH08501145A (ja)	1996-02-06	固相免疫学的検定法
US5316784A (en)	1994-05-31	Process for the production of a solid phase matrix coated with an immunologically active substance
US4163779A (en)	1979-08-07	Test for quantitation of immunoglobulin and identification of abnormal immunoglobulin
CA1340575C (fr)	1999-06-01	Article pour essais immunologiques utilisant des colorants organiques; methodes pour les produire et les utiliser
JP2553852B2 (ja)	1996-11-13	サンプル中の生物学的物質の免疫学的測定法
CA1336759C (fr)	1995-08-22	Mode de dosage d'une substance immunologiquement detectable et recipient approprie pour la reaction
US4495295A (en)	1985-01-22	Immunoassays using support-containing separate antigens and antibodies derived from an immune complex
CA1083036A (fr)	1980-08-05	Methode indirecte pour le dosage des antigenes ou des anticorps sur une surface solide
WO1990015328A1 (fr)	1990-12-13	Essai immunitaire ameliore
US4391795A (en)	1983-07-05	Assay for free thyroid hormone
CA2047742A1 (fr)	1990-08-28	Methode et trousse d'essai diagnostique pour la detection de l'anticardiolipide
US5183735A (en)	1993-02-02	Method and diagnostic test kit for detection of anti-dsDNA antibodies
US4668637A (en)	1987-05-26	Method for detecting and dosing by erythroadsorption a biological substance
US4925786A (en)	1990-05-15	Method of determining blood groups by the solid-phase procedure with blood-group specific antibodies of the immunoglobulin M. type and support and kit for carrying out the method